MedWatch

Biotech-CEO:”It’s the offer of the day - pure and simple.”

A computer-modelling of the toxicology of pharmaceuticals could shorten the preclinical phase considerably and be a huge help to especially start-up companies.

Foto: Colourbox

In a world in which risk willing capital isn’t as willing as it used to be, it is highly important – especially to start-up companies – to have the sustainability of their business idea confirmed as early as possible.

That is also the case for the pharma and biotech companies established in Denmark, and in this regard the not-for-profit organization DHI can be very useful.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier